{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:42:31Z","timestamp":1793479351069,"version":"4.5.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022115","name":"Dutch Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022115","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union\u2019s Horizon 2020","award":["714312"],"award-info":[{"award-number":["714312"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Although sustained DMARD-free remission (SDFR; sustained absence of clinical-synovitis after DMARD-discontinuation) is increasingly achievable in RA, prevalence differs between ACPA-negative (40%) and ACPA-positive RA (5\u201310%). Additionally, early DAS remission (DAS4months&amp;lt;1.6) is associated with achieving SDFR in ACPA-negative, but not in ACPA-positive RA. Based on these differences, we hypothesized that longitudinal patterns of local tissue inflammation (synovitis\/tenosynovitis\/osteitis) also differ between ACPA-negative and ACPA-positive RA patients achieving SDFR. With the ultimate aim being to increase understanding of disease resolution in RA, we studied MRI-detected joint inflammation over time in relation to SDFR development in ACPA-positive RA and ACPA-negative RA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 198 RA patients (94 ACPA-negative, 104 ACPA-positive) underwent repeated MRIs (0\/4\/12\/24\u00a0months) and were followed on SDFR development. The course of MRI-detected total inflammation, and synovitis\/tenosynovitis\/osteitis individually were compared between RA patients who did and did not achieve SDFR, using Poisson mixed models. In total, 174 ACPA-positive RA patients from the AVERT-1 were studied as ACPA-positive validation population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In ACPA-negative RA, baseline MRI-detected inflammation levels of patients achieving SDFR were similar to patients without SDFR but declined 2.0 times stronger in the first year of DMARD treatment [IRR 0.50 (95% CI; 0.32, 0.77); P\u2009&amp;lt;\u20090.01]. This stronger decline was seen in tenosynovitis\/synovitis\/osteitis. In contrast, ACPA-positive RA-patients achieving SDFR, had already lower inflammation levels (especially synovitis\/osteitis) at disease presentation [IRR 0.45 (95% CI; 0.24, 0.86); P\u2009=\u20090.02] compared with patients without SDFR, and remained lower during subsequent follow-up (P\u2009=\u20090.02). Similar results were found in the ACPA-positive validation population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Compared with RA patients without disease resolution, ACPA-positive RA patients achieving SDFR have less severe joint inflammation from diagnosis onwards, while ACPA-negative RA patients present with similar inflammation levels but demonstrate a stronger decline in the first year of DMARD therapy. These different trajectories suggest different mechanisms underlying resolution of RA chronicity in both RA subsets.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac294","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T12:21:41Z","timestamp":1652876501000},"page":"124-134","source":"Crossref","is-referenced-by-count":11,"title":["ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation"],"prefix":"10.1093","volume":"62","author":[{"given":"Marloes","family":"Verstappen","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Centre , Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7332-8072","authenticated-orcid":false,"given":"Xanthe M E","family":"Matthijssen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Centre , Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean E","family":"Connolly","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb , Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Maldonado","sequence":"additional","affiliation":[{"name":"Bristol-Myers Squibb , Princeton, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W J","family":"Huizinga","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Centre , Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette H M","family":"van der Helm-van Mil","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Leiden University Medical Centre , Leiden, The Netherlands"},{"name":"Department of Rheumatology, Erasmus Medical Centre , Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"2022122410111549400_keac294-B1","doi-asserted-by":"crossref","first-page":"e1003296","DOI":"10.1371\/journal.pmed.1003296","article-title":"Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: a longitudinal cohort study in the Netherlands","volume":"17","author":"Matthijssen","year":"2020","journal-title":"PLoS Med"},{"key":"2022122410111549400_keac294-B2","doi-asserted-by":"crossref","first-page":"e001220","DOI":"10.1136\/rmdopen-2020-001220","article-title":"DMARD-free remission as novel treatment target in rheumatoid arthritis: a systematic literature review of achievability and sustainability","volume":"6","author":"Verstappen","year":"2020","journal-title":"RMD Open"},{"key":"2022122410111549400_keac294-B3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/annrheumdis-2014-207080","article-title":"Disease-modifying antirheumatic drug-free sustained remission in rheumatoid arthritis: an increasingly achievable outcome with subsidence of disease symptoms","volume":"75","author":"Ajeganova","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2022122410111549400_keac294-B4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13075-018-1553-8","article-title":"Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study","volume":"20","author":"Burgers","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2022122410111549400_keac294-B5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13075-020-02368-9","article-title":"Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis","volume":"22","author":"Verstappen","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2022122410111549400_keac294-B6","author":"Verstappen"},{"key":"2022122410111549400_keac294-B7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/annrheumdis-2013-204005","article-title":"Concordance between inflammation at physical examination and on MRI in patients with early arthritis","volume":"74","author":"Krabben","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022122410111549400_keac294-B8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13075-019-1824-z","article-title":"Do musculoskeletal ultrasound and magnetic resonance imaging identify synovitis and tenosynovitis at the same joints and tendons? A comparative study in early inflammatory arthritis and clinically suspect arthralgia","volume":"21","author":"Ohrndorf","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2022122410111549400_keac294-B9","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1093\/rheumatology\/keaa658","article-title":"Differing time-orders of inflammation decrease between ACPA subsets in RA patients suggest differences in underlying inflammatory pathways","volume":"60","author":"Matthijssen","year":"2021","journal-title":"Rheumatology"},{"key":"2022122410111549400_keac294-B10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/keq230","article-title":"Predicting arthritis outcomes\u2014what can be learned from the Leiden Early Arthritis Clinic?","volume":"50","author":"de Rooy","year":"2011","journal-title":"Rheumatology"},{"key":"2022122410111549400_keac294-B11","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2022122410111549400_keac294-B12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2022122410111549400_keac294-B13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2014-206106","article-title":"Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period","volume":"74","author":"Emery","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022122410111549400_keac294-B14","first-page":"1385","article-title":"Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system","volume":"30","author":"\u00d8stergaard","year":"2003","journal-title":"J Rheumatol"},{"key":"2022122410111549400_keac294-B15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1136\/ard.2006.068361","article-title":"Introduction of a novel magnetic resonance imaging tenosynovitis score for rheumatoid arthritis: reliability in a multireader longitudinal study","volume":"66","author":"Haavardsholm","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2022122410111549400_keac294-B16","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1093\/rheumatology\/kez674","article-title":"Conventional versus ultrasound treat to target: no difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis","volume":"59","author":"Sundin","year":"2020","journal-title":"Rheumatology"},{"key":"2022122410111549400_keac294-B17","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13075-021-02671-z","article-title":"Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution","volume":"24","author":"Verstappen","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"2022122410111549400_keac294-B18","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.05.467407","article-title":"ACPA-IgG variable domain glycosylation increases before the onset of rheumatoid arthritis and stabilizes thereafter; a cross-sectional study encompassing over 1500 samples","author":"Kissel","year":"2021","journal-title":"bioRxiv"},{"key":"2022122410111549400_keac294-B19","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/rheumatology\/38.12.1213","article-title":"Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials","volume":"38","author":"van Der Heijde","year":"1999","journal-title":"Rheumatology"},{"key":"2022122410111549400_keac294-B20","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1002\/art.21493","article-title":"Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal setting","volume":"52","author":"Haavardsholm","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2022122410111549400_keac294-B21","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1136\/annrheumdis-2016-210887","article-title":"Drug-free sustained remission or spontaneous remission by natural history in rheumatoid arthritis? An unsolved question: comment on the article of Ajeganova et al","volume":"76","author":"Zeidler","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac294\/43750298\/keac294.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/1\/124\/48406345\/keac294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/1\/124\/48406345\/keac294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T10:11:44Z","timestamp":1671876704000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/1\/124\/6588062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,5,18]]},"published-print":{"date-parts":[[2022,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac294","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2022,5,18]]}}}